
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Jubilant Pharmova Q1 FY25 earnings call: Revenue & Margins | Arthneeti
Q1 FY25
1,746 Cr, a 9% increase YoY. Key concall takeaways from Jubilant Pharmova Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Jubilant Pharmova Q2 FY25 earnings call: Revenue & Margins | Arthneeti
Q2 FY25
Q2’FY25 total income grew 5% YoY to Rs. Key concall takeaways from Jubilant Pharmova Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Jubilant Pharmova Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Q4 FY25 consolidated revenue grew 10% YoY to Rs. Key concall takeaways from Jubilant Pharmova Ltd's Q4 FY25 earnings call — and how it ranks against sector…
24 Sept 2026
Jubilant Pharmova Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Q2’FY26 revenue grew by 12% YoY to Rs. Key concall takeaways from Jubilant Pharmova Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Jubilant Pharmova Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
2,143 Cr., up from Rs. Key concall takeaways from Jubilant Pharmova Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
24 Sept 2026
Bayer CropScience Q4 FY18 earnings call: Revenue & Margins | Arthneeti
Q4 FY18
Consumer Health: -2.2% . Key concall takeaways from Bayer CropScience Ltd's Q4 FY18 earnings call — and how it ranks against sector peers.
24 Sept 2026
Bayer CropScience Q2 FY19 earnings call: Revenue & Margins | Arthneeti
Q2 FY19
and portfolio-adjusted): +4.1% . Key concall takeaways from Bayer CropScience Ltd's Q2 FY19 earnings call — and how it ranks against sector peers.
24 Sept 2026
Bayer CropScience Q4 FY19 earnings call: Revenue & Margins | Arthneeti
Q4 FY19
Q1 2019 Crop Science segment sales: €6,444 million, +5.5% year-on-year (YoY) currency. Key concall takeaways from Bayer CropScience Ltd's Q4 FY19 earnings call…
24 Sept 2026
Bayer CropScience Q2 FY20 earnings call: Revenue & Margins | Arthneeti
Q2 FY20
Q2 Revenue from Operations: ₹13,463 million, a +9.1% year-on-year increase (Page 20). Key concall takeaways from Bayer CropScience Ltd's Q2 FY20 earnings call…
24 Sept 2026
Bayer CropScience Q4 FY20 earnings call: Revenue & Margins | Arthneeti
Q4 FY20
Revenue from Operations for Q4 FY 2019-20: ₹36,094 million, up 14% YoY (₹31,673 million in Q4 FY 2018-19) [Page 8] . Key concall takeaways from Bayer…
24 Sept 2026
Bayer CropScience Q2 FY21 earnings call: Revenue & Margins | Arthneeti
Q2 FY21
Revenue from Operations for Q2: ₹13,816 million, a 3% increase year-on-year. Key concall takeaways from Bayer CropScience Ltd's Q2 FY21 earnings call — and how…
24 Sept 2026
Ratnamani Metals & Tubes Q3 FY26: Revenue ₹794.33 Cr, PAT ₹87.91 Cr | Arthneeti
Q3 FY26
Standalone Revenue (Q3 2025-26):** ₹794.33 Crores, down from ₹1,293.53 Crores in Q3 2024-25; approximately 39% decline. Key concall takeaways from Ratnamani…
24 Sept 2026
Bayer CropScience Q4 FY21 earnings call: Revenue & Margins | Arthneeti
Q4 FY21
Q4 2020-21 Revenue from Operations: ₹7,337 million, up 60% YoY (Page 10) . Key concall takeaways from Bayer CropScience Ltd's Q4 FY21 earnings call — and how…
24 Sept 2026
Ratnamani Metals & Tubes Q1 FY27: Revenue ₹740.78 Cr, PAT ₹54.06 Cr | Arthneeti
Q1 FY27
Standalone revenue: ₹740.78 crores, down from ₹1,062.40 crores (approx. Key concall takeaways from Ratnamani Metals & Tubes Ltd's Q1 FY27 earnings call — and…
24 Sept 2026
The Ramco Cements Q2 FY26: Revenue ₹2,241.89 Cr, PAT ₹75.8 Cr | Arthneeti
Q2 FY26
Revenue for 2QFY26 stood at ₹2,241.89 Cr (Standalone) and ₹2,245.28 Cr (Consolidated), up 9% YoY from ₹2,049.50 Cr (Standalone) and ₹2,053.94 Cr (Consolidated)…
24 Sept 2026
The Ramco Cements Q3 FY26: Capex ₹823 Cr | Arthneeti
Q3 FY26
Standalone: ₹2,119.10 Cr (7% YoY increase from ₹1,987.83 Cr in 3QFY25) [Page 15] . Key concall takeaways from The Ramco Cements Ltd's Q3 FY26 earnings call…
24 Sept 2026
The Ramco Cements Q1 FY27: Revenue ₹2,276.18 Cr, PAT ₹31.86 Cr | Arthneeti
Q1 FY27
Standalone total revenue for 1QFY27: ₹2,276.18 Cr, up 10% YoY (Page 10) . Key concall takeaways from The Ramco Cements Ltd's Q1 FY27 earnings call — and how it…
24 Sept 2026
The Ramco Cements Q4 FY26: Capex ₹997 Cr | Arthneeti
Q4 FY26
Standalone: ₹2,618.32 Crores, up 9% YoY (from ₹2,404.90 Crores in 4QFY25) (Page 14) . Key concall takeaways from The Ramco Cements Ltd's Q4 FY26 earnings call…
24 Sept 2026
The Ramco Cements Q4 FY24: Capex ₹1,922 Cr | Arthneeti
Q4 FY24
Standalone: ₹2,687.30 Cr (4% increase YoY from ₹2,581.29 Cr in 4QFY23) . Key concall takeaways from The Ramco Cements Ltd's Q4 FY24 earnings call — and how it…
24 Sept 2026
The Ramco Cements Q1 FY25: Capex ₹281 Cr | Arthneeti
Q1 FY25
Standalone: ₹2,096.87 Crores, down 7% YoY (₹2,248.98 Crores in 1QFY24) . Key concall takeaways from The Ramco Cements Ltd's Q1 FY25 earnings call — and how it…
24 Sept 2026
Arthneeti Pro · Annual
Every earnings call this season,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access